Browse by Changes
Summary of Changes – 1 July 2025
Page last updated: 1 July 2025
Previous versions of the Summary of Changes are available in PDF in the Publications Archive .
- Additions
- Deletions
- Alterations
- Supply Only
- Advance Notices
- Palliative Care
- Highly Specialised Drugs Program (Private Hospital)
- Highly Specialised Drugs Program (Public Hospital)
- Highly Specialised Drugs Program (Community Access)
- Repatriation Pharmaceutical Benefits
- Efficient Funding of Chemotherapy (Private Hospital)
- Efficient Funding of Chemotherapy (Public Hospital)
- Related Pharmaceutical Benefits for Public Hospital use
General Pharmaceutical Benefits
Additions
Addition – Item
14869N | AZITHROMYCIN, azithromycin 500 mg tablet, 3 (Azithromycin Tablets, USP 500 mg (Precision Dose, USA)) |
14870P | AZITHROMYCIN, azithromycin 500 mg tablet, 3 (Azithromycin Tablets, USP 500 mg (Precision Dose, USA)) |
14875X | DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 28 (Slinda) |
14852Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Nepexto) |
14864H | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Vabysmo) |
14873T | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL syringe (Vabysmo) |
14868M | IVOSIDENIB, ivosidenib 250 mg tablet, 60 (Tibsovo) |
14857Y | METHYLPHENIDATE, methylphenidate hydrochloride 18 mg modified release tablet, 60 (Concerta (Switzerland)) |
14861E | METHYLPHENIDATE, methylphenidate hydrochloride 18 mg modified release tablet, 30 (Concerta (Switzerland)) |
14874W | METHYLPHENIDATE, methylphenidate hydrochloride 27 mg modified release tablet, 30 (Concerta (Switzerland)) |
14858B | METHYLPHENIDATE, methylphenidate hydrochloride 36 mg modified release tablet, 30 (Concerta (Switzerland)) |
14862F | METHYLPHENIDATE, methylphenidate hydrochloride 36 mg modified release tablet, 60 (Concerta (Switzerland)) |
14853R | METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 30 (Concerta (Switzerland)) |
14871Q | METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 60 (Concerta (Switzerland)) |
14854T | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada)) |
14851P | RIBOCICLIB, ribociclib 200 mg tablet, 21 (Kisqali) |
14863G | RIBOCICLIB, ribociclib 200 mg tablet, 42 (Kisqali) |
Addition – Brand
10219W | ARIPENA, RA– ARIPIPRAZOLE , aripiprazole 400 mg modified release injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack |
11198J | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11201M | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11202N | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11215G | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11218K | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11221N | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
11222P | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
13687J | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
13697X | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
13708L | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
13774Y | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
1964J | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
3447K | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
3450N | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9455P | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9456Q | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9457R | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9458T | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9459W | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9460X | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9461Y | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9462B | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
5262Y | FILOSIR, NM– FINGOLIMOD , fingolimod 500 microgram capsule, 28 |
14005D | APOHEALTH Urinary Tract Antibacterial, TX– METHENAMINE HIPPURATE , methenamine hippurate 1 g tablet, 100 |
14005D | Chemists' Own Urinary Tract Antibacterial, RW– METHENAMINE HIPPURATE , methenamine hippurate 1 g tablet, 100 |
3124K | APOHEALTH Urinary Tract Antibacterial, TX– METHENAMINE HIPPURATE , methenamine hippurate 1 g tablet, 100 |
3124K | Chemists' Own Urinary Tract Antibacterial, RW– METHENAMINE HIPPURATE , methenamine hippurate 1 g tablet, 100 |
12192Q | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 2.5 mg tablet, 60 |
12197Y | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 2.5 mg tablet, 60 |
13366L | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 2.5 mg tablet, 60 |
11633G | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
11633G | Rivarelto, XW– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
13521P | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
13521P | Rivarelto, XW– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
9466F | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 10 mg tablet, 15 |
9467G | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
9467G | Rivarelto, XW– RIVAROXABAN , rivaroxaban 10 mg tablet, 30 |
9469J | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 10 mg tablet, 15 |
13463N | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 15 mg tablet, 28 |
13463N | Rivarelto, XW– RIVAROXABAN , rivaroxaban 15 mg tablet, 28 |
2160Q | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 15 mg tablet, 42 |
2160Q | Rivarelto, XW– RIVAROXABAN , rivaroxaban 15 mg tablet, 42 |
2691P | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 15 mg tablet, 28 |
2691P | Rivarelto, XW– RIVAROXABAN , rivaroxaban 15 mg tablet, 28 |
13462M | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 20 mg tablet, 28 |
13462M | Rivarelto, XW– RIVAROXABAN , rivaroxaban 20 mg tablet, 28 |
2268J | APO-Rivaroxaban, TX– RIVAROXABAN , rivaroxaban 20 mg tablet, 28 |
2268J | Rivarelto, XW– RIVAROXABAN , rivaroxaban 20 mg tablet, 28 |
11123K | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
11123K | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
13570F | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
13570F | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 |
11131W | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
11131W | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
13511D | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
13511D | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 |
11122J | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
11122J | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
13445P | Omtralo, NM– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
13445P | Sacubitril/Valsartan Alphapharm, FY– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 |
Addition – Equivalence Indicator
10219W | Abilify Maintena, LU– ARIPIPRAZOLE , aripiprazole 400 mg modified release injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack |
14791L | Slinda, HB– DROSPIRENONE , drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 4 x 28 |
14737P | Vabysmo, RO– FARICIMAB , faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
14738Q | Vabysmo, RO– FARICIMAB , faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial |
1658G | Phebra Naproxen Suspension, FF– NAPROXEN , naproxen 125 mg/5 mL oral liquid, 474 mL |
14844G | Ozempic, NO– SEMAGLUTIDE , semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device |
14846J | Ozempic, NO– SEMAGLUTIDE , semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device |
Addition – Note
8200N | AZITHROMYCIN, azithromycin 500 mg tablet, 2 (APO-Azithromycin, AZITHROMYCIN-WGR, Azithromycin Sandoz, Azithromycin Viatris, ZITHRO, Zithromax) |
8336R | AZITHROMYCIN, azithromycin 500 mg tablet, 2 (APO-Azithromycin, AZITHROMYCIN-WGR, Azithromycin Sandoz, Azithromycin Viatris, ZITHRO, Zithromax) |
14791L | DROSPIRENONE, drospirenone 4 mg tablet [24] (&) inert substance tablet [4], 4 x 28 (Slinda) |
1954W | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
1964J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
1963H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
2387P | METHYLPHENIDATE, methylphenidate hydrochloride 18 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
2172H | METHYLPHENIDATE, methylphenidate hydrochloride 27 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
2388Q | METHYLPHENIDATE, methylphenidate hydrochloride 36 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
2432B | METHYLPHENIDATE, methylphenidate hydrochloride 54 mg modified release tablet, 30 (Concerta, METHYLPHENIDATE-TEVA XR, Methylphenidate XR ARX) |
1658G | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Phebra Naproxen Suspension) |
14844G | SEMAGLUTIDE, semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device (Ozempic) |
14846J | SEMAGLUTIDE, semaglutide 0.68 mg/mL injection, 1 x 3 mL pen device (Ozempic) |
Deletions
Deletion – Item
14050L | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 200 (Tegretol CR 200) |
2426Q | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 200 (Tegretol CR 200) |
5038E | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 200 (Tegretol CR 200) |
13918M | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 200 (Tegretol CR 400) |
2431Y | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 200 (Tegretol CR 400) |
5037D | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 200 (Tegretol CR 400) |
1288T | DEXAMETHASONE, dexamethasone 0.1% eye drops, 5 mL (Maxidex) |
5565X | DEXAMETHASONE, dexamethasone 0.1% eye drops, 5 mL (Maxidex) |
14668B | EZETIMIBE, ezetimibe 10 mg tablet, 90 (Ezetimibe USP (Camber, USA)) |
14682R | EZETIMIBE, ezetimibe 10 mg tablet, 90 (Ezetimibe USP (Camber, USA)) |
Deletion – Brand
1007B | Aciclovir APOTEX, TY– ACICLOVIR , aciclovir 200 mg tablet, 90 |
13358C | Allopurinol APOTEX, GX– ALLOPURINOL , allopurinol 100 mg tablet, 200 |
2600W | Allopurinol APOTEX, GX– ALLOPURINOL , allopurinol 100 mg tablet, 200 |
13532F | Amlodipine APOTEX, GX– AMLODIPINE , amlodipine 5 mg tablet, 30 |
2751T | Amlodipine APOTEX, GX– AMLODIPINE , amlodipine 5 mg tablet, 30 |
1887H | Cilamox, AL– AMOXICILLIN , amoxicillin 250 mg/5 mL powder for oral liquid, 100 mL |
3393N | Cilamox, AL– AMOXICILLIN , amoxicillin 250 mg/5 mL powder for oral liquid, 100 mL |
8844L | Bivalirudin APOTEX, TX– BIVALIRUDIN , bivalirudin 250 mg injection, 1 vial |
2460L | Aclor 125, MQ– CEFACLOR , cefaclor 125 mg/5 mL powder for oral liquid, 100 mL |
5046N | Aclor 125, MQ– CEFACLOR , cefaclor 125 mg/5 mL powder for oral liquid, 100 mL |
2461M | Aclor 250, MQ– CEFACLOR , cefaclor 250 mg/5 mL powder for oral liquid, 75 mL |
5047P | Aclor 250, MQ– CEFACLOR , cefaclor 250 mg/5 mL powder for oral liquid, 75 mL |
1169M | Karlor CD, MQ– CEFACLOR , cefaclor 375 mg modified release tablet, 10 |
5045M | Karlor CD, MQ– CEFACLOR , cefaclor 375 mg modified release tablet, 10 |
13385L | Zeklen 10/10 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 10 mg tablet, 30 |
9483D | Zeklen 10/10 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 10 mg tablet, 30 |
13442L | Zeklen 10/20 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 20 mg tablet, 30 |
9484E | Zeklen 10/20 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 20 mg tablet, 30 |
13535J | Zeklen 10/40 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 40 mg tablet, 30 |
8881K | Zeklen 10/40 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 40 mg tablet, 30 |
13595M | Zeklen 10/80 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 80 mg tablet, 30 |
8882L | Zeklen 10/80 mg, AF– EZETIMIBE + SIMVASTATIN , ezetimibe 10 mg + simvastatin 80 mg tablet, 30 |
13377C | Fendex ER, AF– FELODIPINE , felodipine 2.5 mg modified release tablet, 30 |
2361G | Fendex ER, AF– FELODIPINE , felodipine 2.5 mg modified release tablet, 30 |
13561R | Fendex ER, AF– FELODIPINE , felodipine 5 mg modified release tablet, 30 |
2366M | Fendex ER, AF– FELODIPINE , felodipine 5 mg modified release tablet, 30 |
13531E | Fendex ER, AF– FELODIPINE , felodipine 10 mg modified release tablet, 30 |
2367N | Fendex ER, AF– FELODIPINE , felodipine 10 mg modified release tablet, 30 |
14740T | Glyade MR, AF– GLICLAZIDE , gliclazide 30 mg modified release tablet, 100 |
8535F | Glyade MR, AF– GLICLAZIDE , gliclazide 30 mg modified release tablet, 100 |
13848W | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 1 mg tablet, 30 |
8450R | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 1 mg tablet, 30 |
13870B | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 2 mg tablet, 30 |
8451T | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 2 mg tablet, 30 |
14020X | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 3 mg tablet, 30 |
8533D | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 3 mg tablet, 30 |
14055R | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 4 mg tablet, 30 |
8452W | Glimepiride APOTEX, GX– GLIMEPIRIDE , glimepiride 4 mg tablet, 30 |
2546B | Aldiq, AF– IMIQUIMOD , imiquimod 5% cream, 12 x 250 mg sachets |
1542E | Ipratrin, AF– IPRATROPIUM , ipratropium bromide 250 microgram/mL inhalation solution, 30 x 1 mL ampoules |
8238N | Ipratrin Adult, AF– IPRATROPIUM , ipratropium bromide 500 microgram/mL inhalation solution, 30 x 1 mL ampoules |
13940Q | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 10 mg tablet, 30 |
14068K | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 10 mg tablet, 30 |
5449T | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 10 mg tablet, 30 |
8374R | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 10 mg tablet, 30 |
13998R | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 20 mg tablet, 30 |
14069L | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 20 mg tablet, 30 |
5450W | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 20 mg tablet, 30 |
8375T | Leflunomide APOTEX, GX– LEFLUNOMIDE , leflunomide 20 mg tablet, 30 |
13411W | Lercanidipine APOTEX, GX– LERCANIDIPINE , lercanidipine hydrochloride 10 mg tablet, 28 |
8534E | Lercanidipine APOTEX, GX– LERCANIDIPINE , lercanidipine hydrochloride 10 mg tablet, 28 |
13939P | Letrozole APOTEX, GX– LETROZOLE , letrozole 2.5 mg tablet, 30 |
8245Y | Letrozole APOTEX, GX– LETROZOLE , letrozole 2.5 mg tablet, 30 |
13992K | Kevtam 250, AF– LEVETIRACETAM , levetiracetam 250 mg tablet, 60 |
13992K | Levetiracetam Mylan, AL– LEVETIRACETAM , levetiracetam 250 mg tablet, 60 |
8654L | Kevtam 250, AF– LEVETIRACETAM , levetiracetam 250 mg tablet, 60 |
8654L | Levetiracetam Mylan, AL– LEVETIRACETAM , levetiracetam 250 mg tablet, 60 |
14034P | Kevtam 500, AF– LEVETIRACETAM , levetiracetam 500 mg tablet, 60 |
8655M | Kevtam 500, AF– LEVETIRACETAM , levetiracetam 500 mg tablet, 60 |
13937M | Kevtam 1000, AF– LEVETIRACETAM , levetiracetam 1 g tablet, 60 |
13937M | Levetiracetam Mylan, AL– LEVETIRACETAM , levetiracetam 1 g tablet, 60 |
8656N | Kevtam 1000, AF– LEVETIRACETAM , levetiracetam 1 g tablet, 60 |
8656N | Levetiracetam Mylan, AL– LEVETIRACETAM , levetiracetam 1 g tablet, 60 |
10526B | Latuda, SE– LURASIDONE , lurasidone hydrochloride 40 mg tablet, 30 |
10529E | Latuda, SE– LURASIDONE , lurasidone hydrochloride 80 mg tablet, 30 |
1653B | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 10 mg modified release tablet, 28 |
1654C | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 30 mg modified release tablet, 28 |
1655D | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 60 mg modified release tablet, 28 |
1656E | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 100 mg modified release tablet, 28 |
3010K | Nufloxib, AF– NORFLOXACIN , norfloxacin 400 mg tablet, 14 |
8170B | Olanzapine APOTEX, GX– OLANZAPINE , olanzapine 2.5 mg tablet, 28 |
11681T | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
12277E | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
14330F | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
14362X | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
14394N | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
8007K | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
8008L | Pantoprazole APOTEX, TY– PANTOPRAZOLE , pantoprazole 40 mg enteric tablet, 30 |
13588E | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 20 mg tablet, 30 |
2574L | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 20 mg tablet, 30 |
13589F | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 40 mg tablet, 30 |
2594M | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 40 mg tablet, 30 |
11856B | Sevelamer Apotex, TX– SEVELAMER , sevelamer carbonate 800 mg tablet, 180 |
14027G | Sevelamer Apotex, TX– SEVELAMER , sevelamer carbonate 800 mg tablet, 180 |
8144P | IMIGRAN MIGRAINE, AS– SUMATRIPTAN , sumatriptan 50 mg tablet, 2 |
8144P | Imigran, LN– SUMATRIPTAN , sumatriptan 50 mg tablet, 2 |
Deletion – Equivalence Indicator
8844L | BIVALIRUDIN ARX, XT– BIVALIRUDIN , bivalirudin 250 mg injection, 1 vial |
14671E | Tegretol CR 200, NV– CARBAMAZEPINE , carbamazepine 200 mg modified release tablet, 100 |
14673G | Tegretol CR 200, NV– CARBAMAZEPINE , carbamazepine 200 mg modified release tablet, 100 |
14681Q | Tegretol CR 200, NV– CARBAMAZEPINE , carbamazepine 200 mg modified release tablet, 100 |
14662Q | Tegretol CR 400, NV– CARBAMAZEPINE , carbamazepine 400 mg modified release tablet, 100 |
14666X | Tegretol CR 400, NV– CARBAMAZEPINE , carbamazepine 400 mg modified release tablet, 100 |
14680P | Tegretol CR 400, NV– CARBAMAZEPINE , carbamazepine 400 mg modified release tablet, 100 |
1542E | Atrovent, BY– IPRATROPIUM , ipratropium bromide 250 microgram/mL inhalation solution, 30 x 1 mL ampoules |
8238N | Atrovent Adult, BY– IPRATROPIUM , ipratropium bromide 500 microgram/mL inhalation solution, 30 x 1 mL ampoules |
Deletion – Note
13897K | ALOGLIPTIN, alogliptin 6.25 mg tablet, 28 (Nesina) |
2944Y | ALOGLIPTIN, alogliptin 6.25 mg tablet, 28 (Nesina) |
13977P | ALOGLIPTIN, alogliptin 12.5 mg tablet, 28 (Nesina) |
2933J | ALOGLIPTIN, alogliptin 12.5 mg tablet, 28 (Nesina) |
13953J | ALOGLIPTIN, alogliptin 25 mg tablet, 28 (Nesina) |
2986E | ALOGLIPTIN, alogliptin 25 mg tablet, 28 (Nesina) |
10035E | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 1 g tablet, 56 (Nesina Met 12.5/1000) |
13989G | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 1 g tablet, 56 (Nesina Met 12.5/1000) |
10033C | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 500 mg tablet, 56 (Nesina Met 12.5/500) |
14062D | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 500 mg tablet, 56 (Nesina Met 12.5/500) |
10032B | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 56 (Nesina Met 12.5/850) |
14061C | ALOGLIPTIN + METFORMIN, alogliptin 12.5 mg + metformin hydrochloride 850 mg tablet, 56 (Nesina Met 12.5/850) |
14671E | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 (Tegretol CR 200) |
14673G | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 (Tegretol CR 200) |
14681Q | CARBAMAZEPINE, carbamazepine 200 mg modified release tablet, 100 (Tegretol CR 200) |
14662Q | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 (Tegretol CR 400) |
14666X | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 (Tegretol CR 400) |
14680P | CARBAMAZEPINE, carbamazepine 400 mg modified release tablet, 100 (Tegretol CR 400) |
13440J | EZETIMIBE, ezetimibe 10 mg tablet, 30 (APO-Ezetimibe, ARX-EZETIMIBE, BTC Ezetimibe, EZEMICHOL, EZETIMIBE-WGR, Ezetimibe GH, Ezetimibe Sandoz, Ezetrol, Pharmacor Ezetimibe 10, Zient 10mg) |
8757X | EZETIMIBE, ezetimibe 10 mg tablet, 30 (APO-Ezetimibe, ARX-EZETIMIBE, BTC Ezetimibe, EZEMICHOL, EZETIMIBE-WGR, Ezetimibe GH, Ezetimibe Sandoz, Ezetrol, Pharmacor Ezetimibe 10, Zient 10mg) |
Alterations
Alteration – Item Description
From | |
14378R | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
To | |
14378R | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
From | |
14540G | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
To | |
14540G | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
From | |
8406K | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
To | |
8406K | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation inhalation, 200 actuations (Qvar 50) |
From | |
8408M | BECLOMETHASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
To | |
8408M | BECLOMETASONE, beclometasone dipropionate 50 microgram/actuation breath activated inhalation, 200 actuations (Qvar 50 Autohaler) |
From | |
14514X | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
To | |
14514X | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
From | |
14541H | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
To | |
14541H | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
From | |
8407L | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
To | |
8407L | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation inhalation, 200 actuations (Qvar 100) |
From | |
8409N | BECLOMETHASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
To | |
8409N | BECLOMETASONE, beclometasone dipropionate 100 microgram/actuation breath activated inhalation, 200 actuations (Qvar 100 Autohaler) |
Alteration – Note
11207W | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
11223Q | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
3445H | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
3448L | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8637N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8778B | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9035M | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9036N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9037P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9429G | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
11198J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
11202N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
11221N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
11222P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
13687J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
13774Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
3447K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
3450N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
9455P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9457R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9458T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9459W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9461Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9462B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
11208X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
11216H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
11224R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
11225T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
13698Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
13751R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
3446J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
3449M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
9085E | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9087G | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9088H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9089J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9091L | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9431J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
14737P | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
14738Q | FARICIMAB, faricimab 6 mg/0.05 mL intraocular injection, 0.05 mL vial (Vabysmo) |
Alteration – Restriction
14116Y | ABEMACICLIB, abemaciclib 50 mg tablet, 56 (Verzenio) |
14105J | ABEMACICLIB, abemaciclib 100 mg tablet, 56 (Verzenio) |
14134X | ABEMACICLIB, abemaciclib 150 mg tablet, 56 (Verzenio) |
11204Q | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
11207W | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
11223Q | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
3445H | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
3448L | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8637N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8638P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8778B | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
8779C | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9035M | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9036N | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9037P | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
9429G | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
11198J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
11201M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
11202N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
11221N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Nepexto) |
11222P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
3447K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
3450N | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
9455P | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9456Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9457R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9458T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9459W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9460X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9461Y | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
9462B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Brenzys, Enbrel, Nepexto) |
11196G | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
11208X | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
11216H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
11224R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
11225T | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys) |
3446J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
3449M | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
9085E | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9086F | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9087G | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9088H | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9089J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9090K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9091L | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
9431J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Brenzys, Enbrel) |
14181J | OLAPARIB, olaparib 100 mg tablet, 56 (Lynparza) |
14216F | OLAPARIB, olaparib 100 mg tablet, 56 (Lynparza) |
14208T | OLAPARIB, olaparib 150 mg tablet, 56 (Lynparza) |
14215E | OLAPARIB, olaparib 150 mg tablet, 56 (Lynparza) |
Alteration – Manufacturer Code
From | To | ||
13032X | Ruzurgi– AMIFAMPRIDINE , amifampridine 10 mg tablet, 100 | OJ | LD |
12652X | Reagila– CARIPRAZINE , cariprazine 1.5 mg capsule, 30 | CS | IX |
12619E | Reagila– CARIPRAZINE , cariprazine 3 mg capsule, 30 | CS | IX |
12653Y | Reagila– CARIPRAZINE , cariprazine 4.5 mg capsule, 30 | CS | IX |
12622H | Reagila– CARIPRAZINE , cariprazine 6 mg capsule, 30 | CS | IX |
11123K | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 | RM | TX |
13570F | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 24.3 mg + valsartan 25.7 mg tablet, 56 | RM | TX |
11131W | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 | RM | TX |
13511D | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 48.6 mg + valsartan 51.4 mg tablet, 56 | RM | TX |
11122J | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 | RM | TX |
13445P | Valtresto– SACUBITRIL + VALSARTAN , sacubitril 97.2 mg + valsartan 102.8 mg tablet, 56 | RM | TX |
Supply Only
Supply Only – Period Commencing
14335L | GLYCERYL TRINITRATE, glyceryl trinitrate 15 mg/24 hours patch, 30 (Minitran 15) |
8119H | GLYCERYL TRINITRATE, glyceryl trinitrate 15 mg/24 hours patch, 30 (Minitran 15) |
Supply Only – Period Ending
5519L | HYPROMELLOSE + CARBOMER-980, hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g (Genteal gel, HPMC PAA) |
8564R | HYPROMELLOSE + CARBOMER-980, hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g (Genteal gel, HPMC PAA) |
9215B | HYPROMELLOSE + CARBOMER-980, hypromellose 0.3% + carbomer-980 0.2% eye gel, 10 g (Genteal gel, HPMC PAA) |
Supply Only – Addition Equivalence Indicator
This change will impact items which are currently available for supply only
12080T | Ozempic, NO– SEMAGLUTIDE , semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device |
14149Q | Ozempic, NO– SEMAGLUTIDE , semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device |
Supply Only – Addition Note
This change will impact items which are currently available for supply only
12080T | SEMAGLUTIDE, semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device (Ozempic) |
14149Q | SEMAGLUTIDE, semaglutide 1.34 mg/mL injection, 1 x 1.5 mL pen device (Ozempic) |
Advance Notices
1 August 2025
Deletion – Brand
1052J | Aciclovir APOTEX, TY– ACICLOVIR , aciclovir 800 mg tablet, 35 |
11329G | Giotrif, BY– AFATINIB , afatinib 50 mg tablet, 28 |
11342Y | Giotrif, BY– AFATINIB , afatinib 50 mg tablet, 28 |
9438R | GA gel, VF– AMINO ACID FORMULA WITH VITAMINS AND MINERALS WITHOUT LYSINE AND LOW IN TRYPTOPHAN , amino acid formula with vitamins and minerals without lysine and low in tryptophan powder for oral liquid, 30 x 24 g sachets |
14425F | Betoptic, NV– BETAXOLOL , betaxolol 0.5% eye drops, 5 mL |
2825Q | Betoptic, NV– BETAXOLOL , betaxolol 0.5% eye drops, 5 mL |
5544T | Betoptic, NV– BETAXOLOL , betaxolol 0.5% eye drops, 5 mL |
8878G | Durogesic 12, JC– FENTANYL , fentanyl 12 microgram/hour patch, 5 |
8891Y | Durogesic 25, JC– FENTANYL , fentanyl 25 microgram/hour patch, 5 |
8892B | Durogesic 50, JC– FENTANYL , fentanyl 50 microgram/hour patch, 5 |
8893C | Durogesic 75, JC– FENTANYL , fentanyl 75 microgram/hour patch, 5 |
8894D | Durogesic 100, JC– FENTANYL , fentanyl 100 microgram/hour patch, 5 |
8729K | Granisetron-AFT, AE– GRANISETRON , granisetron 3 mg/3 mL injection, 3 mL ampoule |
8730L | Granisetron-AFT, AE– GRANISETRON , granisetron 3 mg/3 mL injection, 3 mL ampoule |
14526M | Montelukast APOTEX, GX– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
14526M | Montelukast Mylan, AF– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
8627C | Montelukast APOTEX, GX– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
8627C | Montelukast Mylan, AF– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
14194C | RA-Morph (NZ), WZ– MORPHINE , morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL |
14204N | RA-Morph (NZ), WZ– MORPHINE , morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL |
10005N | Olmekar HCT 20/5/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
13481M | Olmekar HCT 20/5/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
13482N | Olmekar HCT 40/10/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
13512E | Olmekar HCT 40/5/25, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30 |
13513F | Olmekar HCT 40/5/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
14002Y | Olmekar HCT 40/10/25, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30 |
2836G | Olmekar HCT 40/10/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
2864R | Olmekar HCT 40/5/25, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 25 mg tablet, 30 |
2880N | Olmekar HCT 40/5/12.5, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
2953K | Olmekar HCT 40/10/25, RF– OLMESARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE , olmesartan medoxomil 40 mg + amlodipine 10 mg + hydrochlorothiazide 25 mg tablet, 30 |
14367E | Noumed Paroxetine, VO– PAROXETINE , paroxetine 20 mg tablet, 30 |
2242B | Noumed Paroxetine, VO– PAROXETINE , paroxetine 20 mg tablet, 30 |
8589C | Accuretic 10/12.5mg, PF– QUINAPRIL + HYDROCHLOROTHIAZIDE , quinapril 10 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
8590D | Accuretic 20/12.5mg, PF– QUINAPRIL + HYDROCHLOROTHIAZIDE , quinapril 20 mg + hydrochlorothiazide 12.5 mg tablet, 30 |
8527T | Metalyse, BY– TENECTEPLASE , tenecteplase 50 mg injection [1 vial] (&) inert substance diluent [10 mL syringe], 1 pack |
14636H | Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg Tablets (Laurus Labs, USA), KQ– TENOFOVIR DISOPROXIL + EMTRICITABINE , tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
10622C | Hymenoptera Yellow Jacket Venom, DE– YELLOW JACKET VENOM , yellow jacket venom 550 microgram injection [1 vial] (&) inert substance diluent [9 mL vial], 1 pack |
1 September 2025
Deletion – Brand
1555W | Aciclovir APOTEX, TY– ACICLOVIR , aciclovir 200 mg tablet, 50 |
13575L | Allopurinol APOTEX, GX– ALLOPURINOL , allopurinol 300 mg tablet, 60 |
2604C | Allopurinol APOTEX, GX– ALLOPURINOL , allopurinol 300 mg tablet, 60 |
5296R | Riamet 20mg/120mg Dispersible, NV– ARTEMETHER + LUMEFANTRINE , artemether 20 mg + lumefantrine 120 mg dispersible tablet, 18 |
5265D | Denpax, AF– FENTANYL , fentanyl 12 microgram/hour patch, 5 |
5277R | Denpax, AF– FENTANYL , fentanyl 25 microgram/hour patch, 5 |
5278T | Denpax, AF– FENTANYL , fentanyl 50 microgram/hour patch, 5 |
5279W | Denpax, AF– FENTANYL , fentanyl 75 microgram/hour patch, 5 |
5280X | Denpax, AF– FENTANYL , fentanyl 100 microgram/hour patch, 5 |
10915L | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
10918P | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
10920R | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
10924Y | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
10940T | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
10941W | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
10942X | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
11757T | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
11770L | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
11776T | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
11777W | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
11782D | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
11783E | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
11875B | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
12709X | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
12710Y | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
12722N | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
12759M | Imatinib-APOTEX, TX– IMATINIB , imatinib 100 mg capsule, 60 |
14553Y | Montelukast APOTEX, GX– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
14553Y | Montelukast Mylan, AF– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
8628D | Montelukast APOTEX, GX– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
8628D | Montelukast Mylan, AF– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
13449W | Olmesartan/Amlodipine 20/5 APOTEX, TX– OLMESARTAN + AMLODIPINE , olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30 |
5292M | Olmesartan/Amlodipine 20/5 APOTEX, TX– OLMESARTAN + AMLODIPINE , olmesartan medoxomil 20 mg + amlodipine 5 mg tablet, 30 |
13898L | APOTEX-Pioglitazone, TX– PIOGLITAZONE , pioglitazone 15 mg tablet, 28 |
8694N | APOTEX-Pioglitazone, TX– PIOGLITAZONE , pioglitazone 15 mg tablet, 28 |
13406N | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 5 mg tablet, 30 |
2606E | Rosuvastatin APOTEX, GX– ROSUVASTATIN , rosuvastatin 5 mg tablet, 30 |
1 October 2025
Deletion – Brand
13419G | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 2.5 mg tablet, 28 |
13443M | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 5 mg tablet, 28 |
13444N | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 10 mg tablet, 28 |
8604W | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 2.5 mg tablet, 28 |
8605X | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 5 mg tablet, 28 |
8606Y | NOUMED BISOPROLOL, VO– BISOPROLOL , bisoprolol fumarate 10 mg tablet, 28 |
1475P | Fluconazole APOTEX, GX– FLUCONAZOLE , fluconazole 200 mg capsule, 28 |
14526M | Montelukast APOTEX, GX– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
14526M | Montelukast Mylan, AF– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
14553Y | Montelukast APOTEX, GX– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
14553Y | Montelukast Mylan, AF– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
8627C | Montelukast APOTEX, GX– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
8627C | Montelukast Mylan, AF– MONTELUKAST , montelukast 4 mg chewable tablet, 28 |
8628D | Montelukast APOTEX, GX– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
8628D | Montelukast Mylan, AF– MONTELUKAST , montelukast 5 mg chewable tablet, 28 |
8185T | Olanzapine APOTEX, GX– OLANZAPINE , olanzapine 5 mg tablet, 28 |
13964Y | Olmesartan/Amlodipine 40/5 APOTEX, TX– OLMESARTAN + AMLODIPINE , olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30 |
5293N | Olmesartan/Amlodipine 40/5 APOTEX, TX– OLMESARTAN + AMLODIPINE , olmesartan medoxomil 40 mg + amlodipine 5 mg tablet, 30 |
5470X | Ondansetron Mylan ODT, AF– ONDANSETRON , ondansetron 4 mg orally disintegrating tablet, 4 |
5472B | Ondansetron Mylan ODT, AF– ONDANSETRON , ondansetron 4 mg orally disintegrating tablet, 10 |
13997Q | Tamosin, OX– TAMOXIFEN , tamoxifen 20 mg tablet, 60 |
2110C | Tamosin, OX– TAMOXIFEN , tamoxifen 20 mg tablet, 60 |
Palliative Care
Additions
Addition – Item
14867L | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Pediapharm Naproxen Suspension 25 mg/mL (Medexus Pharma, Canada)) |
Addition – Equivalence Indicator
5397C | Phebra Naproxen Suspension, FF– NAPROXEN , naproxen 125 mg/5 mL oral liquid, 474 mL |
Addition – Note
5397C | NAPROXEN, naproxen 125 mg/5 mL oral liquid, 474 mL (Phebra Naproxen Suspension) |
Deletions
Deletion – Brand
12547J | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 10 mg modified release tablet, 28 |
12500X | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 30 mg modified release tablet, 28 |
12544F | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 60 mg modified release tablet, 28 |
12483B | Morphine MR Mylan, AF– MORPHINE , morphine sulfate pentahydrate 100 mg modified release tablet, 28 |
Advance Notices
1 August 2025
Deletion – Brand
12474M | Durogesic 75, JC– FENTANYL , fentanyl 75 microgram/hour patch, 5 |
12477Q | Durogesic 50, JC– FENTANYL , fentanyl 50 microgram/hour patch, 5 |
12504D | Durogesic 25, JC– FENTANYL , fentanyl 25 microgram/hour patch, 5 |
12509J | Durogesic 100, JC– FENTANYL , fentanyl 100 microgram/hour patch, 5 |
12541C | Durogesic 12, JC– FENTANYL , fentanyl 12 microgram/hour patch, 5 |
14187Q | RA-Morph (NZ), WZ– MORPHINE , morphine hydrochloride trihydrate 10 mg/mL oral liquid, 200 mL |
1 September 2025
Deletion – Brand
12491K | Denpax, AF– FENTANYL , fentanyl 12 microgram/hour patch, 5 |
12516R | Denpax, AF– FENTANYL , fentanyl 25 microgram/hour patch, 5 |
12526G | Denpax, AF– FENTANYL , fentanyl 75 microgram/hour patch, 5 |
12533P | Denpax, AF– FENTANYL , fentanyl 100 microgram/hour patch, 5 |
12546H | Denpax, AF– FENTANYL , fentanyl 50 microgram/hour patch, 5 |
Highly Specialised Drugs Program (Private Hospital)
Additions
Addition – Item
14865J | MARIBAVIR, maribavir 200 mg tablet, 28 (Livtencity) |
Addition – Brand
13326J | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
9641K | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
Addition – Note
6367D | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
Addition – Caution
13326J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
9641K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
13332Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
9615C | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Deletions
Deletion – Brand
12139X | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
12143D | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
12148J | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
6429J | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
11838C | Sevelamer Apotex, TX– SEVELAMER , sevelamer carbonate 800 mg tablet, 180 |
Deletion – Note
14189T | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Deletion – Restriction
14189T | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Alterations
Alteration – Note
14279M | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
14280N | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
13266F | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
12938Y | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
13326J | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
9641K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
13332Q | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
9615C | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Alteration – Restriction
14279M | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
14280N | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
13266F | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
12938Y | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
Highly Specialised Drugs Program (Public Hospital)
Additions
Addition – Item
14856X | MARIBAVIR, maribavir 200 mg tablet, 28 (Livtencity) |
Addition – Brand
13319B | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
5735W | Nepexto, GQ– ETANERCEPT , etanercept 50 mg/mL injection, 4 x 1 mL pen devices |
Addition – Note
5734T | ETANERCEPT, etanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack (Enbrel) |
Addition – Caution
13319B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
5735W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
13308K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
5733R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Deletions
Deletion – Brand
12134P | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
12140Y | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
12145F | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
5618Q | Bosentan Mylan, AF– BOSENTAN , bosentan 62.5 mg tablet, 60 |
11855Y | Sevelamer Apotex, TX– SEVELAMER , sevelamer carbonate 800 mg tablet, 180 |
Deletion – Note
14195D | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Deletion – Restriction
14195D | ANIFROLUMAB, anifrolumab 300 mg/2 mL injection, 2 mL vial (Saphnelo) |
Alterations
Alteration – Note
14227T | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
14228W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
13276R | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
12936W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
13319B | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
5735W | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL pen devices (Enbrel, Nepexto) |
13308K | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
5733R | ETANERCEPT, etanercept 50 mg/mL injection, 4 x 1 mL syringes (Enbrel) |
Alteration – Restriction
14227T | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 80 mg + tezacaftor 40 mg + ivacaftor 60 mg granules [28] (&) ivacaftor 59.5 mg granules [28], 56 (Trikafta) |
14228W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg granules [28] (&) ivacaftor 75 mg granules [28], 56 (Trikafta) |
13276R | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 (Trikafta) |
12936W | ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTOR, elexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 (Trikafta) |
Highly Specialised Drugs Program (Community Access)
Additions
Addition – Item
14866K | MARIBAVIR, maribavir 200 mg tablet, 28 (Livtencity) |
Advance Notices
1 August 2025
Deletion – Brand
10310P | Tenofovir APOTEX, TX– TENOFOVIR DISOPROXIL , tenofovir disoproxil fumarate 300 mg tablet, 30 |
11992E | Tenofovir APOTEX, TX– TENOFOVIR DISOPROXIL , tenofovir disoproxil fumarate 300 mg tablet, 30 |
14637J | Emtricitabine and Tenofovir Disoproxil Fumarate 200 mg/300 mg Tablets (Laurus Labs, USA), KQ– TENOFOVIR DISOPROXIL + EMTRICITABINE , tenofovir disoproxil fumarate 300 mg + emtricitabine 200 mg tablet, 30 |
1 October 2025
Deletion – Brand
10348P | Lamivudine Alphapharm, AF– LAMIVUDINE , lamivudine 150 mg tablet, 60 |
10310P | Viread, GI– TENOFOVIR DISOPROXIL , tenofovir disoproxil fumarate 300 mg tablet, 30 |
11992E | Viread, GI– TENOFOVIR DISOPROXIL , tenofovir disoproxil fumarate 300 mg tablet, 30 |
Repatriation Pharmaceutical Benefits
Deletions
Deletion – Item
4571N | NICOTINE, nicotine 7 mg/24 hours patch, 7 (QuitX) |
4572P | NICOTINE, nicotine 14 mg/24 hours patch, 7 (QuitX) |
4573Q | NICOTINE, nicotine 21 mg/24 hours patch, 7 (QuitX) |
Deletion – Brand
4134N | Aldiq, AF– IMIQUIMOD , imiquimod 5% cream, 12 x 250 mg sachets |
4559Y | Aldiq, AF– IMIQUIMOD , imiquimod 5% cream, 12 x 250 mg sachets |
Advance Notices
1 August 2025
Deletion – Brand
4468E | Rynacrom, SW– CROMOGLYCATE , sodium cromoglycate 2% nasal spray, 26 mL |
Efficient Funding of Chemotherapy (Private Hospital)
Additions
Addition – Item
14860D |
NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo) ; nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
14872R |
NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo) ; nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
Addition – Brand
10763L | BENDAMUSTINE EUGIA, YG– BENDAMUSTINE , bendamustine hydrochloride 25 mg injection, 1 vial |
10763L | BENDAMUSTINE EUGIA, YG– BENDAMUSTINE , bendamustine hydrochloride 100 mg injection, 1 vial |
7249M | IRINOTECAN EUGIA, YG– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
7249M | IRINOTECAN EUGIA, YG– IRINOTECAN , irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Deletions
Deletion – Brand
7229L | Adriamycin, PF– DOXORUBICIN , doxorubicin hydrochloride 200 mg/100 mL injection, 100 mL vial |
7249M | Omegapharm Irinotecan, OE– IRINOTECAN , irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 2 mL vial |
7249M | Irinotecan Alphapharm, AF– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
7249M | Omegapharm Irinotecan, OE– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
7249M | Irinotecan Alphapharm, AF– IRINOTECAN , irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Alterations
Alteration – Manufacturer Code
From | To | ||
10383L | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
10402L | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
10589H | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
10597R | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
7264H | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
7265J | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
7266K | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
7267L | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
Advance Notices
1 August 2025
Deletion – Brand
10699D | Arsenic Trioxide-AFT, AE– ARSENIC , arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
7241D | Arsenic Trioxide-AFT, AE– ARSENIC , arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
12219D | Bortezomib Sandoz, SZ– BORTEZOMIB , bortezomib 3.5 mg injection, 1 vial |
7234R | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 1 g/20 mL injection, 20 mL vial |
7234R | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 5 g/100 mL injection, 100 mL vial |
7239B | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 1 g/20 mL injection, 20 mL vial |
7239B | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 5 g/100 mL injection, 100 mL vial |
Efficient Funding of Chemotherapy (Public Hospital)
Additions
Addition – Item
14855W |
NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo) ; nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
14859C |
NIVOLUMAB,
nivolumab 40 mg/4 mL injection, 4 mL vial (Opdivo) ; nivolumab 100 mg/10 mL injection, 10 mL vial (Opdivo) |
Addition – Brand
10760H | BENDAMUSTINE EUGIA, YG– BENDAMUSTINE , bendamustine hydrochloride 25 mg injection, 1 vial |
10760H | BENDAMUSTINE EUGIA, YG– BENDAMUSTINE , bendamustine hydrochloride 100 mg injection, 1 vial |
4451G | IRINOTECAN EUGIA, YG– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
4451G | IRINOTECAN EUGIA, YG– IRINOTECAN , irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Deletions
Deletion – Brand
4361M | Adriamycin, PF– DOXORUBICIN , doxorubicin hydrochloride 200 mg/100 mL injection, 100 mL vial |
4451G | Omegapharm Irinotecan, OE– IRINOTECAN , irinotecan hydrochloride trihydrate 40 mg/2 mL injection, 2 mL vial |
4451G | Irinotecan Alphapharm, AF– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
4451G | Omegapharm Irinotecan, OE– IRINOTECAN , irinotecan hydrochloride trihydrate 100 mg/5 mL injection, 5 mL vial |
4451G | Irinotecan Alphapharm, AF– IRINOTECAN , irinotecan hydrochloride trihydrate 500 mg/25 mL injection, 25 mL vial |
Alterations
Alteration – Manufacturer Code
From | To | ||
10391X | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
10401K | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
10581X | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
10588G | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
4632T | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
4639E | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
4650R | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
4703M | Kanjinti– TRASTUZUMAB , trastuzumab 420 mg injection, 1 vial | JU | XT |
Advance Notices
1 August 2025
Deletion – Brand
10691Q | Arsenic Trioxide-AFT, AE– ARSENIC , arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
4371C | Arsenic Trioxide-AFT, AE– ARSENIC , arsenic trioxide 10 mg/10 mL injection, 10 x 10 mL ampoules |
12227M | Bortezomib Sandoz, SZ– BORTEZOMIB , bortezomib 3.5 mg injection, 1 vial |
4394G | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 1 g/20 mL injection, 20 mL vial |
4394G | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 5 g/100 mL injection, 100 mL vial |
4431F | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 1 g/20 mL injection, 20 mL vial |
4431F | Fluorouracil Ebewe, SZ– FLUOROURACIL , fluorouracil 5 g/100 mL injection, 100 mL vial |
Related Pharmaceutical Benefits for Public Hospital use
Advance Notices
1 August 2025
Deletion – Brand
5899L | Granisetron-AFT, AE– GRANISETRON , granisetron 3 mg/3 mL injection, 3 mL ampoule |
1 October 2025
Deletion – Brand
5857G | Ondansetron Mylan ODT, AF– ONDANSETRON , ondansetron 4 mg orally disintegrating tablet, 4 |